Key highlights
- The R&D Center in France became fully operational in July 2025.
- The facility spans 3,000 square meters and employs 170 people.
- Solar panels will supply up to 30% of the building's electricity.
Opening and Location
Aptar Pharma has inaugurated a new R&D Center in Le Vaudreuil and Val-de-Reuil, France, enhancing its research capabilities in drug delivery.
Facility Details
The 3,000-square-meter facility, operational since July 2025, employs 170 staff and features advanced technologies like digital simulation and AI to accelerate drug development.
Sustainability Features
The center includes rooftop solar panels, a heat recovery unit, and a rainwater harvesting system, with solar panels providing up to 30% of its electricity needs.
Strategic Importance
This expansion is part of Aptar's global innovation strategy, emphasizing the development of innovative drug dosing and dispensing solutions.
